Adrenal Involvement in Antiphospholipid Syndrome – ARP Rheumatology
ARP Rheumatology shared a post on LinkedIn:
“Adrenal involvement in antiphospholipid syndrome (APS) is rare but potentially fatal.
This case-based review highlights that APS-related adrenal failure may present atypically, leading to diagnostic delay – particularly in men. Awareness of this manifestation is essential, as early diagnosis and prompt initiation of anticoagulation and hormonal replacement significantly improve outcomes.
Key message: APS should be considered in patients with new-onset primary adrenal insufficiency, and adrenal involvement should be systematically evaluated in APS patients with compatible symptoms”
Title: Adrenal failure as an antiphospholipid syndrome manifestation: case-based review
Authors: Mariana Emília Santos, Catarina Gama, Bernardo Marques, Tiago Saldanha, Joana Tremoceiro, Maria Helena Lourenço, Maria João Gonçalves, Manuela Costa, Alexandre Sepriano
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 11, 2026, 10:02Hind Hanani: Understanding the Use of Antiphospholipid Syndrome Guidelines Worldwide
-
Jan 11, 2026, 09:58Exploring the Role of Antiphospholipid Antibodies in Severe Preeclampsia – RheumNow
-
Jan 11, 2026, 09:52Jamie Agunsday: Understanding Pregnancy-Related Deaths
-
Jan 11, 2026, 09:48Heghine Khachatryan: Rethinking First-Line Therapy for Iron Deficiency Anemia in Women
-
Jan 11, 2026, 09:44AdhesioRT Test Models Endometrial Receptivity to Optimize Implantation Timing – RBMO
-
Jan 11, 2026, 09:21ACOG Announces Maternal Health Awareness Day 2026 Webinar
-
Jan 11, 2026, 06:59John Cush: Subcutaneous Anifrolumab Effective in Lupus
-
Jan 10, 2026, 06:50Owen Xian Wen Tan: New Insights on β2-Glycoprotein I in Thrombosis Regulation
-
Jan 10, 2026, 06:35John Cush: Assess Reproductive Health in SLE Clinic Visits